| Literature DB >> 26085388 |
Al B Benson1, Alan P Venook1, Tanios Bekaii-Saab1, Emily Chan1, Yi-Jen Chen1, Harry S Cooper1, Paul F Engstrom1, Peter C Enzinger1, Moon J Fenton1, Charles S Fuchs1, Jean L Grem1, Axel Grothey1, Howard S Hochster1, Steven Hunt1, Ahmed Kamel1, Natalie Kirilcuk1, Lucille A Leong1, Edward Lin1, Wells A Messersmith1, Mary F Mulcahy1, James D Murphy1, Steven Nurkin1, Eric Rohren1, David P Ryan1, Leonard Saltz1, Sunil Sharma1, David Shibata1, John M Skibber1, Constantinos T Sofocleous1, Elena M Stoffel1, Eden Stotsky-Himelfarb1, Christopher G Willett1, Kristina M Gregory1, Deborah Freedman-Cass1.
Abstract
The NCCN Guidelines for Rectal Cancer begin with the clinical presentation of the patient to the primary care physician or gastroenterologist and address diagnosis, pathologic staging, surgical management, perioperative treatment, posttreatment surveillance, management of recurrent and metastatic disease, and survivorship. The NCCN Rectal Cancer Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize major discussion points from the 2015 NCCN Rectal Cancer Panel meeting. Major discussion topics this year were perioperative therapy options and surveillance for patients with stage I through III disease.Entities:
Mesh：
Year: 2015 PMID： 26085388 DOI： 10.6004/jnccn.2015.0087
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908